The GMP cytokines market is expected to reach US$ 158. 13 million in 2027 from US$ 84. 72 million in 2019; it is estimated to grow at a CAGR of 8. 1% from 2020 to 2027. The growth of the GMP cytokines market is mainly attributed to increase in acceptance of cytokines cancer and autoimmune therapies and potential contribution in the stem cell therapy.
New York, Feb. 23, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "GMP Cytokines Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Type, and Application, and Geography" - https://www.reportlinker.com/p06027539/?utm_source=GNW However, high cost associated with GMP cytokines therapy is projected to deter the market growth.
Stem cell research has been widely investigated globally to improve the quality of human health.The stem cells play a prominent role in replacement and reconstruction of damaged tissues.
Based on extensive research on stem cells, many scientists have appealed that the cells could probably generate novel therapies for various chronic diseases, such as cardiovascular disease and cancers.With the advent of new technologies and research, the cytokines growth factor is also contributing to the utilization of stem cells for novel therapeutics.
Hematopoietic stem cell therapy cytokines (growth factors) play a major role in the regulation of multiple parameters of hematopoietic stem cells, such as self-renewal, quiescence, apoptosis, differentiation, and mobilization.Moreover, the growth factors are also responsible for cooperative actions of several other growth factors and other hormones for binding of receptors on these cells.
Hematopoietic stem cells are currently used for treating more than 80 medical diseases, which include diseases of the immune system, blood disorders, metabolic disorders, neurological disorders, genetic disorders, and several types of cancers, including leukemia and lymphoma. Further, extensively increasing number of product launches for the stem cell therapies is further extended to boost the market growth. For instance, in December 2019, CEVEC and CellGenix announced launch of GMP TGF-1 for the cell and gene therapy industry. Such product launches are anticipated to boost the growth of the GMP cytokines market during the forecast period.
Based on type, the GMP cytokines market is segmented into TNF, interleukins, growth factors, and others.The growth factors segment held the largest share of the market in 2019; whereas, the TNF segment is anticipated to register the highest CAGR in the market during the forecast period.
The growth factors segment held the largest share owing to high demand for cell culture-based research in the field of wound management, oncology, cardiovascular, and other medical fields.For instance, the study Advances in surgical applications of growth factors for wound healing was published in April 2019 and was conducted in Shimane University Faculty of Medicine, Japan.
The GMP cytokines market, by configuration, is segmented into cell/gene therapy, tissue-engineered products, others. The cell and gene therapy segment held the largest share of the market in 2019; whereas, the tissue-engineered products segment is anticipated to register the highest CAGR in the market during the forecast period.
The World Health Organization, National Health Service, Centers for Disease Control and Prevention, King Abdullah International Medical Research Center, and Japanese Society of Molecular Cell Biology of Macrophages, along with company websites, are the major primary and secondary sources referred to while preparing this report.Read the full report: https://www.reportlinker.com/p06027539/?utm_source=GNW
About ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
Story continues
Go here to see the original:
- Overview of stem cells therapy in amyotrophic lateral sclerosis - DocWire News - February 27th, 2021
- Cord Blood Banking Leader Cryo-Cell International Enters Into An Exclusive License Agreement with Duke University - GlobeNewswire - February 27th, 2021
- Microchip can help scientists study the regenerative potential of mice heart cells - News-Medical.Net - February 27th, 2021
- GMP Cytokines Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Type, and Application, and Geography - GlobeNewswire - February 27th, 2021
- Spinal Cord Injuries Repaired In Patients Using Their Own Stem Cells In Preliminary Trial - IFLScience - February 27th, 2021
- Uncovering Secrets of Heart Regeneration in Baby Mice - Technology Networks - February 27th, 2021
- Researchers identify cells responsible for maintenance and regeneration of liver - News-Medical.Net - February 27th, 2021
- Global $79.23 Bn Regenerative Medicine Markets, Analysis 2015-2019 & Forecasts 2020-2026 - ResearchAndMarkets.com - Business Wire - February 27th, 2021
- Relapsed/Refractory DLBCL Undergoes Rapid Evolution With CAR T-Cell Therapy, ADCs, and Bispecific Antibodies - OncLive - February 27th, 2021
- Proliferation tracing reveals regional hepatocyte generation in liver homeostasis and repair - Science Magazine - February 27th, 2021
- A Canadian success story: world-first to treat Fabry disease with gene therapy - Newswise - February 27th, 2021
- The global cell therapy market is expected to reach US$ 12,563.23 million by 2027 from US$ 7,260.50 million in 2019 - Yahoo Sports - February 23rd, 2021
- The global organoids market is expected to reach US$ 3,420.40 million by 2027 from US$ 689.47 million in 2019 - Yahoo Finance - February 23rd, 2021
- Therapeutic Solutions International Uses StemVacs Platform to Generate Personalized Adoptive T Cell Therapy Targeting Cancer Stem Cells - PRNewswire - February 23rd, 2021
- First experience of the use of a generic of plerixafor in peripheral blood stem cell mobilization in multiple myeloma and lymphoma patients - DocWire... - February 23rd, 2021
- Coya Therapeutics Announces Formation of Scientific Advisory Board - GlobeNewswire - February 23rd, 2021
- Outlook on the Cell Therapy Biomanufacturing Global Market to 2025 - by Product Type, Application and Region - GlobeNewswire - February 23rd, 2021
- Anthony Nolan Cell & Gene Therapy Services and ONK Therapeutics Announce Collaboration - BioSpace - February 23rd, 2021
- Incyte Announces Acceptance and Priority Review of sNDA for Jakafi (ruxolitinib) as a Treatment for Patients with Chronic Graft-Versus-Host Disease -... - February 23rd, 2021
- In B-Cell NHL, Off-the-Shelf NK Immunotherapy Shows Promise When Used With Chemotherapy and ASCT - Cancer Network - February 23rd, 2021
- Global Cell Therapy Biomanufacturing Market (2020 to 2025) - Featuring Lonza Group, Merck & Novartis Among Others - ResearchAndMarkets.com -... - February 21st, 2021
- Meet the women hoping to recruit more stem cells donors from Black communities - CTV News - February 19th, 2021
- Stem Cell Banking Market Report 2021 | Growth and Opportunities Analysis - BioSpace - February 19th, 2021
- The Untapped Potential of Cell and Gene Therapy - AJMC.com Managed Markets Network - February 19th, 2021
- Mouth Sores from Chemo: Symptoms, Causes, and Treatments - Healthline - February 19th, 2021
- World Regenerative Medicine Market Outlook to 2030, by Product, Material and Application - PRNewswire - February 19th, 2021
- Cholangiocyte organoids can repair bile ducts after transplantation in the human liver - Science - February 19th, 2021
- CAR T-Cell Therapy Carves Out a Role in Multiple Myeloma - OncLive - February 19th, 2021
- Recombinant Growth Factors to Account for Over 45% of Overall Demand through 2031: Persistence Market Research - PRNewswire - February 19th, 2021
- Off-the-Shelf NK Immunotherapy With Chemotherapy and Transplant Shows Early Activity in B-Cell NHL - OncLive - February 19th, 2021
- EMA: Lentiviral thalassemia treatment on hold pending cancer investigation - Regulatory Focus - February 19th, 2021
- Novartis, Gates Foundation pursue a simpler gene therapy for sickle cell - STAT - February 19th, 2021
- Research Associate in Stem Cells and Regenerative Medicine job with KINGS COLLEGE LONDON | 246711 - Times Higher Education (THE) - February 17th, 2021
- Takeda announces expansion of stem cell therapy production facility in Ireland - Gov.ie - February 17th, 2021
- Braunschweig Makes the Case for Earlier Use of CAR T-Cell Therapy in DLBCL - OncLive - February 17th, 2021
- Off-the-Shelf NK Immunotherapy Is Safe and Promising in B-Cell NHL With Chemotherapy and Transplant - Targeted Oncology - February 17th, 2021
- Lineage to Host Virtual OPC1 Investor & Analyst Day on February 22, 2021 - Business Wire - February 17th, 2021
- Global Opportunity Analysis in the Regenerative Medicine Market to 2030 - A $172.17 Billion Market by 2030 - GlobeNewswire - February 17th, 2021
- Discovery for turning on cell repair in tissues and organs - Monash University - February 17th, 2021
- AI project to power the future of stem cell manufacturing - TechCentral.ie - February 17th, 2021
- Creative Medical Technology Holdings Files Patent on Prevention of Organ Transplant Rejection using ImmCelz - PRNewswire - February 17th, 2021
- From organoids to cell painting: Investigate 3D and complex biology using advanced methods in high-content cellular imaging and analysis - Drug Target... - February 17th, 2021
- CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results - GlobeNewswire - February 17th, 2021
- Smart Stem Cells Made From Fat Have the Power to Heal - Freethink - February 14th, 2021
- Researchers discover factor that triggers muscle stem cells to heal - Drug Target Review - February 12th, 2021
- Stem cell study illuminates the cause of an inherited heart disorder | Penn Today - Penn Today - February 12th, 2021
- Neurons from patient blood cells enable researchers to test treatments for genetic brain disease - Brown University - February 12th, 2021
- Florida boy battling cancer in need of blood stem cell donor - ABC Action News - February 12th, 2021
- New research aims to explore functions of bile acids in the gut stem cell niche - News-Medical.Net - February 12th, 2021
- Therapeutic Solutions International Acquires Stem Cell Therapy That Successfully Completed FDA Double Blind Placebo Controlled Efficacy Study for Lung... - February 12th, 2021
- Types of leukemia: Prevalence, treatment options, and prognosis - Medical News Today - February 12th, 2021
- Novel finding could lead to better treatments for Type 1 and Type 2 diabetes - News-Medical.Net - February 12th, 2021
- Jasper Therapeutics Announces Launch of New Clinical Trial with National Heart, Lung, and Blood Institute to Evaluate JSP191 in Sickle Cell Disease -... - February 12th, 2021
- Notch Therapeutics Closes $85 Million Series A Financing to Develop Pipeline of Renewable Stem Cell-Derived Cancer Immunotherapies - PRNewswire - February 12th, 2021
- Researchers discover a recipe for cyclical regeneration of bioengineered hair - News-Medical.net - February 12th, 2021
- Ensoma Launches to Pioneer Next-Generation In Vivo Approach to Deliver First Off-the-shelf Genomic Medicines - Business Wire - February 12th, 2021
- Apamistamab Conditioning Treatment Induces High Rates of HCT Success in AML - OncLive - February 12th, 2021
- AlloVir Research Presented at the 2021 Transplantation & Cellular Therapy Meeting Digital Experience - Business Wire - February 12th, 2021
- Stem cell therapy treatment introduced in Pakistan - The Nation - February 8th, 2021
- Regenerative Medicine Market to be Valued at USD 6.49 Billion by 2027 | The Escalating Burden of Chronic Diseases and Genetic Aberrations will be the... - February 5th, 2021
- Stem cells' efficacy confirmed in treating ototoxic hearing loss - Korea Biomedical Review - February 5th, 2021
- iSpecimen expands offerings to support regenerative medicine, adding cryopreserved stem and immune cells to existing biospecimens available through... - February 3rd, 2021
- Ibrutinib-Based Regimen Safe and Effective in R/R Primary CNS Lymphoma, Early Results Show - Targeted Oncology - February 2nd, 2021
- MRD Could Prove to Be a Valuable Tool in Multiple Myeloma - OncLive - February 2nd, 2021
- Stem Cell Therapy Market Size to Reach USD 5,040 Million by 2028 | Rising Public-Private Investments and Developing Regulatory Framework for Stem Cell... - January 31st, 2021
- Stem cell and allergy clinics receive CBER untitled letters - Regulatory Focus - January 31st, 2021
- ProgenCell - Stem Cell Therapies offers an updated Stem Cell Therapy for Anti Aging Protocol - PR Web - January 31st, 2021
- Exacis Biotherapeutics Announces Key Addition To Its Executive Leadership Team With Dirk Huebner MD Joining As Chief Medical Officer - PRNewswire - January 31st, 2021
- Athersys to Host a Virtual Investor Day - Business Wire - January 31st, 2021
- Medicine by Design researchers focus on promoting self-repair of the brain - News@UofT - January 31st, 2021
- A 73-Year-Old Male With Mantle Cell Lymphoma - Targeted Oncology - January 31st, 2021
- Caladrius Biosciences Treats First Patient in the Phase 2b FREEDOM Trial of CLBS16 for the Treatment of Coronary Microvascular Dysfunction - Cath Lab... - January 31st, 2021
- Elevian Targets Aging to Solve Humanity's Toughest Diseases - BioSpace - January 31st, 2021
- Protein identified that may help treat Parkinsons disease - Medical News Today - January 31st, 2021
- Researchers from U of T, UBC focus on promoting self-repair of the brain - News@UofT - January 28th, 2021
- Valentina Greco Receives the 2021 ISSCR Momentum Award < Yale School of Medicine - Yale School of Medicine - January 28th, 2021
- Stem Cell Therapy Market 2021: Global Key Players, Trends, Share, Industry Size, Segmentation, Forecast To 2027 KSU | The Sentinel Newspaper - KSU |... - January 28th, 2021
- Stem Cell Recruitment Therapy Registration Awarded by US Patent & Trademark Office for Russell Health - PRNewswire - January 28th, 2021
- Cell and Gene Therapy Firms Gear up to Revolutionize Manufacturing - Labiotech.eu - January 28th, 2021
- Vertex Announces FDA Clearance of Investigational New Drug (IND) Application for VX-880, a Novel Cell Therapy for the Treatment of Type 1 Diabetes... - January 28th, 2021
Recent Comments